Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level

Lignende værker

• The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma
  af: Zhang, Qiuyi, et al.
  Udgivet: (2016)
• Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients
  af: Su, Jian, et al.
  Udgivet: (2017)
• High Resolution Melting Analysis for Detecting p53 Gene Mutations in Patients with Non-small Cell Lung Cancer
  af: Zhihong CHEN, et al.
  Udgivet: (2011-10-01)
• Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis
  af: Zhang, Qiuyi, et al.
  Udgivet: (2016)
• Intratumoral heterogeneity in EGFR mutant NSCLC results in divergent resistance mechanisms in response to EGFR tyrosine kinase inhibition
  af: Soucheray, Margaret, et al.
  Udgivet: (2015)